VivoSeq
Other

Fed

0

Pipeline Programs↗

3

Active Trials↗

34

Companies Involved↗

Fed is an early-stage landscape with 0 programs across 34 companies. The most active players are Teva, Mylan Pharmaceuticals Inc, Novartis.

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Teva logo

Teva

0 programs

PreclinicalMylan Pharmaceuticals Inc logo

Mylan Pharmaceuticals Inc

0 programs

PreclinicalNovartis logo

Novartis

0 programs

PreclinicalGSK logo

GSK

0 programs

PreclinicalP

Par Pharmaceutical, Inc.

0 programs

PreclinicalPfizer logo

Pfizer

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

231

clinical trials

Completed216 · 94%
Unknown status10 · 4%
Not yet recruiting2 · 1%
Withdrawn1 · 0%
Available1 · 0%
Recruiting1 · 0%

Clinical Trials

Trial Activity

231 trials

Phenylalanine, Methionine and Histidine Requirements in TPN Fed Neonates
Recruiting·TThe Hospital for Sick Children·N/A·NCT05562310·60 enrolled
Bioequivalence Study of Pentoxifylline 400 Mg in Healthy Subjects Under Fasting and Fed Conditions
Not yet recruiting·CCentro de Atencion e Investigacion Medica·Phase 4·NCT06823362·40 enrolled
Isoleucine, Leucine, Valine and Tryptophan Requirements in TPN Fed Neonates
Not yet recruiting·TThe Hospital for Sick Children·N/A·NCT06372314·80 enrolled
OTR Tablet 40 mg Fed-state Bioequivalence Study
Completed·MMundipharma (China) Pharmaceutical Co. Ltd·Phase 1·NCT03398330·42 enrolled
Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions
Completed·OOverseas Pharmaceuticals, Ltd.·Phase 1·NCT06589921·24 enrolled
Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fed Male.
Completed·Boehringer Ingelheim logoBoehringer Ingelheim·Phase 1·NCT02417844·34 enrolled
Topiramate 25 mg Capsules Under Fed Conditions
Completed·Teva logoTeva·Phase 1·NCT00904943·18 enrolled
Bioavailability of Oxymorphone Hydrochloride 40 mg Extended Release Tablets Under Fed Conditions
Completed·Novartis logoNovartis·Phase 1·NCT00857142·32 enrolled
A Bioequivalence Study of Isosorbide-5-Mononitrate Extended-Release Tablets Under Fed Conditions in Healthy Subjects
Completed·Qilu Pharmaceutical Co., Ltd. logoQilu Pharmaceutical Co., Ltd.·Phase 1·NCT03557580·12 enrolled
Bioequivalency Study of Torsemide Tablets Under Fed Conditions
Completed·RRoxane Laboratories·N/A·NCT00602615·28 enrolled
Bioequivalence Study of Terbinafine Hydrochloride Tablets, 250 mg of Dr. Reddy's Under Fed Conditions
Completed·—·Phase 1·NCT01286701·18 enrolled
Bioequivalence Study of Pantoprazole Sodium 40 mg Delayed Release Tablets Fed Study
Completed·RRanbaxy Laboratories Limited·N/A·NCT01654718·40 enrolled
Paxil CR Bioequivalence Study Brazil - Fed Administration
Completed·GSK logoGSK·Phase 1·NCT01339247·60 enrolled
Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fed Condition
Completed·IIPCA Laboratories Ltd.·Phase 1·NCT01831687·36 enrolled
Fed Bioequivalence Study of CBZ Formulations
Completed·CCenter for Clinical Pharmacology Research Bdbeq S.A.·Phase 1·NCT02132897·20 enrolled
Page 1 of 16

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)